Schizophreniform Disorders (DBCOND0031772)

Identifiers

Synonyms
Schizophreniform Disorder / Schizophreni-form Disorder / Schizophreniform illness / Schizophreniform disorder (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT00709202
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gaintreatment2completed
NCT00361543
Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophreniatreatment4completed
NCT00421954
Open-label Ziprasidone Study for Psychosis Treatment in Adolescentstreatment3completed
NCT00715377
Anticholinergic Burden in SchizophreniatreatmentNot Availableterminated
NCT01321177
An Integrated Program for the Treatment of First Episode of PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT01866098
Naltrexone for Antipsychotic-Induced Weight GaintreatmentNot Availablecompleted
NCT00511628
Study on the Safety of Risperidone on Obese or Overweight Patients With SchizophreniaNot AvailableNot Availableterminated
NCT01425671
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease StatesNo drug interventionsNot AvailableNot Availablecompleted
NCT03757988
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance LifeNo drug interventionstreatmentNot Availablecompleted
NCT01999309
Simvastatin Addition for Patients With Recent-onset Schizophreniatreatment3completed
NCT04203056
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episodetreatment4terminated
NCT02533232
Minocycline Augmentation of Clozapine for Treatment Resistant Schizophreniatreatment1unknown_status
NCT00287352
Study of Amantadine for Weight Stabilization During Olanzapine Treatmenttreatment1completed
NCT00686400
A German Multicenter Study on Toxoplasma Gondii in First-episode SchizophreniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00847600
Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset SchizophreniaNo drug interventionstreatment4completed
NCT02267070
Enhancing Cognitive Training Through Exercise After a First Schizophrenia EpisodeNo drug interventionstreatmentNot Availablecompleted
NCT02160249
RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)No drug interventionssupportive_careNot Availablecompleted
NCT01731119
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescentstreatment2completed
NCT02823041
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia EpisodeNo drug interventionstreatmentNot Availablecompleted
NCT02131116
Integrated Metacognitive Therapy in First Episode PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT01786239
Omega-3 Dietary Supplements in SchizophreniatreatmentNot Availablecompleted
NCT02787122
Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT03201757
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831No drug interventionstreatment3completed
NCT02566057
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT01855074
An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorderstreatment4completed
NCT03043820
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disordertreatment3completed
NCT00465920
Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset PsychosisNo drug interventionstreatment2unknown_status
NCT02033382
Biomarkers in First Episode SchizophreniaNo drug interventionsNot AvailableNot Availablecompleted
NCT01828931
Lifestyle Intervention for Diabetes and Weight Management in PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT00314327
Optimizing Response in Psychosis Studytreatment4terminated
NCT01913327
Antipsychotic Effects on Brain Function in Schizophreniatreatment4terminated
NCT02131129
rTMS in First Episode PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT00681629
Schizophrenic Patients in Integrated Caretreatment4terminated
NCT00791440
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral TherapyNo drug interventionstreatmentNot Availablecompleted
NCT01764568
Contrasting Group Therapy Methods for PsychosisNo drug interventionstreatmentNot Availableterminated
NCT01029769
Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of SchizophreniatreatmentNot Availablecompleted
NCT01269710
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01248195
Optimization of Treatment and Management of Schizophrenia in Europetreatment4completed
NCT01555814
Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site CopenhagendiagnosticNot Availablecompleted
NCT04013555
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophreniaother1 / 2recruiting
NCT00929955
Role of Anti-Inflammatory Agents in Patients With Schizophreniatreatment1completed
NCT00716755
Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.treatmentNot Availablecompleted
NCT01425684
Brain Circuits in Schizophrenia and SmokingNo drug interventionsNot AvailableNot Availablecompleted
NCT00825045
Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With SchizophreniatreatmentNot Availableunknown_status
NCT00312598
Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and QuetiapineNot AvailableNot Availablecompleted
NCT05890183
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia EpisodeNo drug interventionstreatmentNot Availablerecruiting
NCT00465283
Donepezil Double Blind Trial for ECT Memory Disfunctiontreatment4unknown_status
NCT01481883
Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?treatment4completed
NCT00391261
An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.treatment4completed
NCT02137993
Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophreniatreatment4completed
NCT02949232
Prednisolone Addition for Patients With Recent-onset Psychotic Disordertreatment4terminated
NCT00246259
A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosistreatment4completed
NCT00749970
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With SchizophreniaNo drug interventionsNot AvailableNot Availablecompleted
NCT00206570
Clinical Estradiol Trial in Women With Schizophreniatreatment2completed
NCT00492349
Varenicline Adjunctive Treatment in Schizophreniatreatment4completed
NCT03061136
Clonazepam Effects on Brain Oscillations and Cognition in Schizophreniatreatment4withdrawn
NCT02074319
RCT of Methotrexate Added to Treatment As Usual in Schizophreniatreatment1completed
NCT02212041
Electronic Cigarettes in Smokers With Mental IllnessNo drug interventionsotherNot Availablecompleted
NCT00399334
PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT01780116
Effectiveness of Adherence Therapy for SchizophreniaNo drug interventionshealth_services_research1 / 2completed
NCT00734435
Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjectstreatment2terminated
NCT00206557
The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Studytreatment2completed
NCT01041274
DECIFER: Depression and Citalopram In First Episode Recoverytreatment4completed
NCT00349973
Clinical Trial of Dipyridamole in SchizophreniatreatmentNot Availablecompleted
NCT01888627
Integrated Care in Psychotic Disorders With Severe Mental IllnessNo drug interventionstreatmentNot Availablerecruiting
NCT01216891
Multi-disciplinary Treatment for Patients Experiencing First Episode of PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT00337662
Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophreniatreatment4completed
NCT00434980
Family-Directed Cognitive Adaptation Program for Individuals With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT01602029
Randomized Double Blind Placebo Control Study in Patients With Schizophreniatreatment2completed
NCT01075295
Prevention of Weight Gain in Early PsychosesNo drug interventionspreventionNot Availablecompleted
NCT02095938
Association of Amisulpride Response in Schizophrenia With Brain Imagebasic_science4unknown_status
NCT00617214
Schizophrenic Patients Taking Part in Integrated Care ProgramNo drug interventionsNot AvailableNot Availableterminated
NCT05538832
Remote State Representation in Early PsychosisNo drug interventionstreatment0recruiting
NCT06251908
REWRITALIZE Your Recovery - Evaluation of a Creative Writing Group InterventionNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT04268303
Dexmedetomidine in the Treatment of Agitation Associated With Schizophreniatreatment3completed
NCT04418011
Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum DisordersNo drug interventionstreatmentNot Availablecompleted
NCT03067311
Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness TherapyNo drug interventionstreatmentNot Availablecompleted
NCT04113993
Bazedoxifene -Treatment for Women With Schizophreniatreatment4recruiting
NCT03632278
Mindfulness Psychoeducation Program for SchizophreniaNo drug interventionstreatmentNot Availableunknown_status
NCT01082588
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophreniatreatment4completed
NCT00157313
Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode PsychosisNo drug interventionstreatmentNot Availableunknown_status
NCT04093518
Estradiol as add-on to Antipsychoticstreatment3unknown_status
NCT03079024
Minnesota Community-Based Cognitive Training in Early PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT04004416
Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosisbasic_science4recruiting
NCT05416658
Shared Decision Making for Antipsychotic MedicationsNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT05784948
Safety and Efficacy of Virtual Reality Mindfulness in Patients With PsychosisNo drug interventionspreventionNot Availablecompleted
NCT00161057
Functional Brain Activation Patterns in Schizophrenia, Measured Before and After TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT03559426
Research Into Antipsychotic Discontinuation and Reduction TrialNo drug interventionstreatment4completed
NCT05109065
Peripheral Immune System in Individuals With SchizophreniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03974620
Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early SchizophreniaNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00595504
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophreniatreatment4completed
NCT04173572
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control TrialNo drug interventionstreatmentNot Availablecompleted
NCT06278246
Investigating the Muscarinic System in Schizophrenia Using Positron Emission TomographyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00419146
Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidantstreatment2 / 3completed
NCT06041646
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disordertreatment4completed
NCT04298450
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis InterventionNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04673851
Horyzons: Implementation in Clinical PracticeNo drug interventionstreatmentNot Availablecompleted
NCT06423651
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum DisordersNo drug interventionstreatmentNot Availablerecruiting
NCT00407277
Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophreniabasic_scienceNot Availablecompleted
NCT03510741
Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.other2completed
NCT03848234
Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disordertreatment3completed
NCT05877716
EPI-MINN: Targeting Cognition and Motivation - NationalNo drug interventionstreatmentNot Availablerecruiting
NCT06002958
Horyzons: Implementation and Integration in Clinical PracticeNo drug interventionstreatmentNot Availablerecruiting
NCT04497857
Academic-Community EPINET (AC-EPINET)No drug interventionshealth_services_researchNot Availablerecruiting
NCT05974527
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Departmenttreatment4not_yet_recruiting
NCT03919760
Early Psychosis Intervention - Spreading Evidence-based TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT00515489
Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic PatientsNot AvailableNot Availableterminated
NCT06118268
iTBS to Enhance Social Cognition in People With PsychosisNo drug interventionstreatmentNot Availablerecruiting
NCT03187769
Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disordertreatment3completed
NCT05658510
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)treatment3active_not_recruiting
NCT00796081
A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disordertreatment1completed
NCT00222495
A Comparative Study of New Medications for Psychosis in AdolescentstreatmentNot Availablecompleted
NCT05756855
Young Adults with Violent Behavior During Early PsychosisNo drug interventionshealth_services_researchNot Availablerecruiting